Patent details

Basic Information

Publication number:

EP2248895

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP100090166

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Combination therapy associating a TGF-beta antagonist with a chemotherapeutic agent

French Title of Invention:

Thérapie combinatoire associant un antagoniste du TGF-beta avec un agent chimiothérapeutique

German Title of Invention:

Kombinations-therapie die ein TGF-beta Antagonisten mit einem Chemotherapeutikum assoziiert

SPC Number:

Dates

Filing date:

20/12/2004

Grant date:

06/07/2016

EP Publication Date:

06/07/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/11/2010

EP B1 Publication Date:

06/07/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/12/2016

Expiration date:

20/12/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/07/2016

 

 

Name:

Autotelic LLC

Address:

17870 Castleton Street, Suite 250, City of Industry CA 91748, United States (US)

Inventor

1

Name:

Schlingensiepen Karl-Hermann

Address:

Germany (DE)

2

Name:

Schlingensiepen Reimar

Address:

Germany (DE)

Priority

1

Priority Number:

03029367

Priority Date:

19/12/2003

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

541771 P

Priority Date:

05/02/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 15/113;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages